Included In This Lesson
Outline
What is the generic name?
LORLATINIB
What is the Trade Name for LORLATINIB?
Lorbrena
What are the Indications for LORLATINIB?
- 1 INDICATIONS AND USAGE LORBRENA ® is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test. LORBRENA is a kinase inhibitor indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test. ( 1 , 2.1 )
View Our Nursing Pharmacology Course
References: https://open.fda.gov/
Other Pharm Resources